USPTO serial 79434375
BIOSTEALTH
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 15, 2026
- Examiner
- HENRY, NAKIA D
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with BIOSTEALTH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
JP
JP
JP
JP
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Miki Motohashi Iino
Miki Motohashi Iino Millen, White, Zelano & Branigan, P.C.2200 Clarendon Boulevard Suite 1400Arlington, VA 22201United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Stents; catheters; cardiac pacemakers; defibrillators; therapeutic apparatus and instruments, namely stents, implantable scaffolds comprising artificial materials for maintaining tissue contour and medical devices for opening the narrowed section of the lumen; medical guidewires; nanorobots for medical purposes for targeted drug delivery in blood vessels and prevention or treatment of thrombosis and stenosis; drug-coated stents for thrombosis; implantable subcutaneous drug delivery devices, namely implantable drug delivery pumps and implantable drug delivery ports; medical apparatus and instruments, namely cardiovascular, endovascular and implantable medical devices and structural medical apparatus, in particular stents, stent grafts, coils, artificial heart valves, artificial hearts, heart-lung machines (cardiopulmonary bypass apparatus), catheters, guidewires, and stent delivery systems, all for structural support, implantation, or circulation management in the human body | ACTIVE | — |
| 042 | Medical research; testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Global Vascular Co., Ltd.
- Other trademarks owned by Global Vascular Co., Ltd.
- Other trademarks owned by Global Vascular Co., Ltd.
- Other trademarks owned by Global Vascular Co., Ltd.
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named BIOSTEALTH
- Prosecution event R.PR explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 15, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 15, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 15, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 21, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 21, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 16, 2026 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 15, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 1, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 1, 2026 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jun 18, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 18, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 18, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 18, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 18, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 23, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 22, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 22, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 18, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 18, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 18, 2026 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 18, 2026 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Mar 12, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 20, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 20, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 29, 2026 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jan 27, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 26, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 23, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 10, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 10, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 9, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |